lonidamine has been researched along with Glioma in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (23.08) | 18.7374 |
| 1990's | 5 (38.46) | 18.2507 |
| 2000's | 2 (15.38) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (23.08) | 2.80 |
| Authors | Studies |
|---|---|
| Guo, L; Hai, L; Li, R; Lu, J; Mu, B; Peng, Y; Shi, Y; Wu, Y; Zhao, Y | 1 |
| Du, Y; Hai, L; Li, R; Lu, J; Peng, Y; Shi, Y; Wu, Y; Yang, Z; Zhao, Y; Zhao, Z | 1 |
| Guo, L; Hai, L; Li, R; Lu, J; Peng, Y; Wu, Y; Zhao, Y | 1 |
| Amoroso, R; Bartoli, B; Benvenuti, L; Gagliardi, R; Gremigni, V; Lena, A; Rechichi, M; Rossi, L; Salvetti, A; Scarcelli, V; Vecchio, D | 1 |
| Kalia, VK; Narayanan, V; Prabhakara, S | 1 |
| Carapella, CM; Delle Chiaie, S; Iandolo, B; Riccio, A | 1 |
| Bourgeois, Y; Dutrillaux, B; Magdelénat, H; Miccoli, L; Oudard, S; Poirson, F; Poisson, M; Poupon, MF; Vassault, A | 1 |
| Benassi, M; Bruno, T; Castiglione, S; Delpino, A; Floridi, A; Gentile, FP; Iacobini, C; Paggi, MG | 1 |
| Dutrillaux, B; Miccoli, L; Oudard, S; Poupon, MF | 1 |
| Danjoux, CE; DeSanctis, AJ; Feeley, MM; Fisher, B; Maroun, J; Martin, L; Raaphorst, GP | 1 |
| Sales, S; Schiffer, D; Soffietti, R | 1 |
| Caputo, A; Carapella, CM; Cattani, F; Ciottoli, GB; Floridi, A; Iandolo, B; Paggi, MG; Raus, L; Riccio, A | 1 |
| Delaney, S; Feeley, M; Lobreau, AU; Raaphorst, GP; Szekely, JG | 1 |
2 review(s) available for lonidamine and Glioma
| Article | Year |
|---|---|
[Targeting the gene of glucose metabolism for the treatment of advanced gliomas].
Topics: Antineoplastic Agents; Brain; Brain Neoplasms; Chromosome Deletion; Diazepam; Glioma; Glucose; Glycolysis; Hexokinase; Humans; Indazoles; Mitochondria; Neoplasm Proteins; Porins; Tumor Cells, Cultured | 1998 |
Lonidamine in malignant brain tumors.
Topics: Antineoplastic Agents; Brain Neoplasms; Glioma; Humans; Indazoles | 1991 |
1 trial(s) available for lonidamine and Glioma
| Article | Year |
|---|---|
The potential role of lonidamine (LND) in the treatment of malignant glioma. Phase II study.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Brain Neoplasms; Clinical Trials as Topic; Dose-Response Relationship, Drug; Female; Glioma; Humans; Indazoles; Male; Middle Aged; Neoplasm Recurrence, Local; Pyrazoles | 1989 |
10 other study(ies) available for lonidamine and Glioma
| Article | Year |
|---|---|
Multiple targeted doxorubicin-lonidamine liposomes modified with p-hydroxybenzoic acid and triphenylphosphonium to synergistically treat glioma.
Topics: Animals; Cell Line, Tumor; Doxorubicin; Drug Delivery Systems; Glioma; Hydroxybenzoates; Indazoles; Liposomes; Mice | 2022 |
pH-redox responsive cascade-targeted liposomes to intelligently deliver doxorubicin prodrugs and lonidamine for glioma.
Topics: Cell Line, Tumor; Doxorubicin; Glioma; Glucose; Humans; Hydrogen-Ion Concentration; Indazoles; Ligands; Liposomes; Oxidation-Reduction; Prodrugs | 2022 |
Glucose and Triphenylphosphonium Co-Modified Redox-Sensitive Liposomes to Synergistically Treat Glioma with Doxorubicin and Lonidamine.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Doxorubicin; Drug Carriers; Drug Delivery Systems; Glioma; Glucose; Humans; Indazoles; Liposomes; Organophosphorus Compounds; Oxidation-Reduction; Tumor Cells, Cultured | 2021 |
Drugs targeting the mitochondrial pore act as cytotoxic and cytostatic agents in temozolomide-resistant glioma cells.
Topics: Acridine Orange; Betulinic Acid; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Cell Death; Cell Line, Tumor; Cell Survival; Cyclosporine; Cytostatic Agents; Dacarbazine; Drug Resistance, Neoplasm; ErbB Receptors; Glioma; Humans; Indazoles; Membrane Potential, Mitochondrial; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Pentacyclic Triterpenes; Polymerase Chain Reaction; Retinoids; Temozolomide; Triterpenes | 2009 |
Modulation of cellular radiation responses by 2-deoxy-D-glucose and other glycolytic inhibitors: implications for cancer therapy.
Topics: Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; Deoxyglucose; Glioma; Humans; Indazoles; Micronucleus Tests; Radiation-Sensitizing Agents | 2009 |
Lonidamine in primary malignant brain tumors. Preliminary report.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Astrocytoma; Brain Neoplasms; Electrocardiography; Electromyography; Female; Glioma; Humans; Indazoles; Male; Middle Aged; Pyrazoles; Tomography, X-Ray Computed | 1984 |
Mitochondria-bound hexokinase as target for therapy of malignant gliomas.
Topics: Adenosine Triphosphate; Adult; Aged; Animals; Female; Glioma; Hexokinase; Humans; Indazoles; Lactates; Male; Mice; Mice, Nude; Middle Aged; Mitochondria; Neoplasm Transplantation | 1995 |
Thermal behavior of a human glioma cell line and its response to combinations of hyperthermia and lonidamine.
Topics: Antineoplastic Agents; Combined Modality Therapy; Glioma; Hot Temperature; Humans; Hyperthermia, Induced; Indazoles; Tumor Cells, Cultured | 1993 |
The effect of lonidamine (LND) on radiation and thermal responses of human and rodent cell lines.
Topics: Animals; Antineoplastic Agents; Carcinoma, Squamous Cell; Cell Line, Transformed; Cell Survival; Cricetinae; Fibroblasts; Glioma; Humans; Hyperthermia, Induced; Indazoles; Melanoma; Mice; Neoplasms; Radiotherapy; Tumor Cells, Cultured | 1991 |
Morphological effects of lonidamine on two human-tumor cell culture lines.
Topics: Antineoplastic Agents; Cell Line; Cell Survival; Glioma; Humans; Indazoles; Leukemia, T-Cell; Microscopy, Electron; Microscopy, Electron, Scanning; Organelles; Pyrazoles; Tumor Cells, Cultured | 1989 |